Hernia Mesh Devices Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Hernia Type (Inguinal Hernia, Incisional Hernia, Femoral Hernia), By Mesh Type (Biologic Mesh, Synthetic Mesh), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 4.79 Billion
CAGR (2026-2031)	6.93%
Fastest Growing Segment	Synthetic Mesh
Largest Market	North America
Market Size (2031)	USD 7.16 Billion

Market Overview

The Global Hernia Mesh Devices Market will grow from USD 4.79 Billion in 2025 to USD 7.16 Billion by 2031 at a 6.93% CAGR. Hernia mesh devices are surgical implants, typically constructed from synthetic or biologic materials, designed to reinforce weakened or damaged tissue during hernia repair procedures. The market is primarily propelled by the rising global prevalence of hernias, often associated with aging populations and obesity, alongside the increasing adoption of tension-free repair techniques that reduce recovery times. These factors create a sustained demand for effective reinforcement solutions, distinguishing the fundamental need for these devices from temporary technological shifts.

Despite these advancements, the market faces significant impediments related to product safety, specifically the risk of post-surgical complications such as infection, chronic pain, and recurrence. These issues often lead to costly litigation and stringent regulatory scrutiny, potentially slowing product adoption. According to the American College of Surgeons, in 2024, research indicated that short and long-term rates of hernia recurrence in abdominal wall reconstruction remained between 1.4% and 3%, highlighting the persistent clinical challenges regarding device performance.

Key Market Drivers

The increasing adoption of minimally invasive and robotic-assisted surgeries is a primary catalyst reshaping product utilization within the Global Hernia Mesh Devices Market. As surgeons prioritize techniques that minimize patient trauma and reduce recovery times, there is a surge in demand for specialized mesh implants designed for deployment through trocars and seamless integration with robotic platforms. This surgical evolution requires devices that maintain structural integrity while offering the pliability necessary for precise, robotically controlled placement. The scale of this shift is evident in procedural volumes; according to Intuitive Surgical, July 2025, in the 'Quarterly Report for Quarter Ending June 30, 2025', approximately 775,000 da Vinci procedures were performed globally during the quarter, reflecting a 17% increase compared to the prior year, highlighting the expanding reliance on robotic modalities for soft tissue repairs.

Technological advancements in biologic and composite mesh materials further stimulate market growth by addressing clinical demands for reduced foreign body reactions. Manufacturers are increasingly introducing hybrid and fully absorbable solutions that provide temporary mechanical support while promoting natural tissue regeneration, mitigating long-term complications associated with permanent synthetics. This innovation is exemplified by recent product introductions; according to Becton, Dickinson and Company (BD), April 2025, in the press release 'BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair', the company commercialized the Phasix ST Umbilical Hernia Patch, the first fully absorbable device engineered specifically for this indication. The commercial viability of these advanced materials is robust; according to TELA Bio, November 2025, in the 'Third Quarter 2025 Financial Results', revenue for their reinforced tissue matrix portfolio reached $20.7 million, representing a 9% growth over the previous year.

Download Free Sample Report

Key Market Challenges

Product safety concerns, specifically the risks of post-surgical complications such as infection and chronic pain, constitute a formidable barrier hindering the expansion of the Global Hernia Mesh Devices Market. These clinical issues frequently result in severe patient outcomes that necessitate costly corrective surgeries and long-term medical management. Consequently, manufacturers face intense legal liabilities and escalating litigation expenses, which significantly drain financial resources that could otherwise be allocated to research and development. This environment of heightened scrutiny compels regulatory bodies to enforce stricter approval processes, thereby extending product development lifecycles and delaying the market entry of new innovations.

Furthermore, the persistence of adverse events directly erodes confidence among surgeons and patients, leading to hesitation in adopting mesh-based procedures for complex cases. According to the American College of Surgeons, in 2024, clinical data revealed that short and long-term wound complication rates in abdominal wall reconstruction ranged between 7% and 10%. Such statistics underscore the continued clinical volatility associated with these implants. This uncertainty not only slows the uptake of existing products but also creates a cautious market atmosphere where safety concerns overshadow technological advancements, ultimately restricting the overall market growth trajectory.

Key Market Trends

The expansion of mesh utilization in Ambulatory Surgical Centers (ASCs) is fundamentally altering the market landscape, driven by a systemic shift toward cost-efficient, outpatient care models. Healthcare providers and payers are increasingly prioritizing these facilities for routine hernia repairs to leverage lower operational overheads and streamlined procedural workflows compared to traditional inpatient hospital settings. This transition is further enabled by improved anesthetic techniques that facilitate same-day discharge without compromising patient safety. The scale of this migration is evidenced by financial performance in the sector; according to Surgery Partners, Inc., March 2025, in the press release 'Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2024 Results', the company reported that full-year revenues grew 13.5% to $3.1 billion, a surge largely attributed to increased case volumes within their short-stay surgical network.

Concurrently, the advancement of self-fixating and sutureless mesh innovations is reshaping surgical approaches by eliminating the need for penetrating fixation devices such as tacks and staples. These next-generation implants incorporate micro-grip technologies or adhesive backings that anchor the mesh securely to the tissue, significantly reducing the risk of nerve entrapment and chronic post-operative pain often associated with mechanical fixation. Additionally, these designs reduce operative time, offering a dual benefit of clinical safety and procedural efficiency. This efficacy is supported by recent clinical data; according to Surgical Endoscopy, February 2025, in the study 'Laparoscopic inguinal hernia repair with self-fixated meshes', trial results indicated that patients treated with self-gripping mesh demonstrated a low recurrence rate of 1.1%, validating the device's reliability relative to conventional methods.

Segmental Insights

The Synthetic Mesh segment is currently identified as the fastest-growing category within the Global Hernia Mesh Devices Market due to its favorable balance of efficacy and affordability. This robust growth is primarily driven by the high tensile strength and durability of synthetic materials, which are essential for minimizing the risk of hernia recurrence in patients. Furthermore, these devices offer a cost-effective alternative to biologic meshes, making them a preferred choice for healthcare institutions managing tight budgets. Continued product clearances by the U.S. Food and Drug Administration further validate the safety of these devices and support their widespread adoption for tension-free repairs.

Regional Insights

North America maintains a dominant position in the Global Hernia Mesh Devices Market, primarily driven by a well-established healthcare infrastructure and a high volume of surgical repair procedures. The region benefits significantly from favorable reimbursement policies and the strong presence of key medical device manufacturers. Furthermore, strict regulatory oversight by the U.S. Food and Drug Administration ensures rigorous product safety standards, fostering confidence among healthcare providers. Rising healthcare expenditure and increasing patient awareness regarding effective treatment options continue to support the market's expansion across the United States and Canada.

Recent Developments

• In April 2025, W.L. Gore & Associates expanded its global footprint by launching the GORE SYNECOR Preperitoneal Biomaterial in Europe, the Middle East, and South Africa. This tri-layer hybrid device was developed to provide a long-term solution for hernia repair by combining a permanent synthetic strength layer with a bioabsorbable tissue-building scaffold. The product was designed for use in preperitoneal placement during open, laparoscopic, and robotic surgeries. Its launch in these regions aimed to offer surgeons a material that facilitates tissue ingrowth while minimizing the risk of complications associated with permanent mesh contact with viscera.
• In April 2025, Becton, Dickinson and Company (BD) announced the commercial availability of the Phasix ST Umbilical Hernia Patch following U.S. FDA 510(k) clearance. This device was marketed as the industry's first fully bioabsorbable mesh specifically designed for the repair of umbilical hernias. The patch is composed of poly-4-hydroxybutyrate (P4HB), a biologically derived polymer that degrades over time, and features a hydrogel barrier to minimize tissue attachment. The product was developed to provide a resorbable alternative to permanent synthetic meshes, addressing patient demand for materials that do not leave a permanent implant in the body.
• In April 2024, TELA Bio, Inc. announced the commercial launch of its OviTex IHR (Inguinal Hernia Repair) Reinforced Tissue Matrix in the United States market. This specific configuration of their reinforced biologic portfolio was designed to address the clinical requirements of laparoscopic and robotic-assisted inguinal hernia repair procedures. The device featured a multi-layer construction of ovine rumen interwoven with polymer suture to provide strength while minimizing the permanent synthetic footprint. The company introduced the product in various shapes to accommodate different surgical techniques and anatomical needs associated with groin hernia repairs.
• In April 2024, Deep Blue Medical Advances launched a new configuration of its hernia repair portfolio known as the T-Line Mini. This smaller version of the company’s flagship mesh was specifically engineered to treat umbilical hernias and other small abdominal wall defects. The product incorporated the company's proprietary design that eliminates the traditional mesh-suture-tissue interface, which is often a point of failure in repairs. By integrating suture-like extensions directly into the mesh, the device was developed to increase anchoring strength and distribute tension more evenly across the repair site.

Key Market Players

• Johnson & Johnson
• W.L Gore and Associates, Inc.
• LifeCell Corporation
• BIOMÉRIEUX SA
• Baxter International Inc.
• Hernia Mesh S.R.L
• Cook Medical Inc
• B. Braun Melsungen AG
• Atrium Medical Corp
• Becton, Dickinson and Company

By Hernia Type	By Mesh Type	By Region
Inguinal Hernia Incisional Hernia Femoral Hernia	Biologic Mesh Synthetic Mesh	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Hernia Mesh Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Hernia Mesh Devices Market, By Hernia Type:

• Inguinal Hernia
• Incisional Hernia
• Femoral Hernia

• Hernia Mesh Devices Market, By Mesh Type:

• Biologic Mesh
• Synthetic Mesh

• Hernia Mesh Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE